Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)

PHASE4CompletedINTERVENTIONAL

Enrollment

401

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

November 30, 2006

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Mometasone Furoate Nasal Spray (MFNS)

MFNS 50 mcg/spray: self-administered, two sprays per nostril (ie, 200 mcg QD), once daily (each morning), for 28 days.

OTHER

Placebo

Matching placebo nasal spray: 2 sprays per nostril once daily for 28 days